Temelimab Uses, Dosage, Side Effects and more
Temelimab is under investigation in clinical trial NCT02782858 (Clinical Trial Assessing the HERV-W Env Antagonist Gnbac1 for Efficacy in MS).
| Attribute | Details |
|---|---|
| Trade Name | Temelimab |
| Generic | Temelimab |
| Temelimab Other Names | Temelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
